标题
Biomarkers for neurodegenerative diseases
作者
关键词
-
出版物
NATURE MEDICINE
Volume 27, Issue 6, Pages 954-963
出版商
Springer Science and Business Media LLC
发表日期
2021-06-04
DOI
10.1038/s41591-021-01382-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
- (2021) Justin S. Sanchez et al. Science Translational Medicine
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
- (2021) Oskar Hansson et al. Alzheimers & Dementia
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
- (2021) Niklas Mattsson‐Carlgren et al. EMBO Molecular Medicine
- Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study
- (2021) Ming-Kai Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease
- (2021) Jacob W. Vogel et al. NATURE MEDICINE
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- (2021) Sebastian Palmqvist et al. NATURE MEDICINE
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
- (2021) Rik Ossenkoppele et al. JAMA Neurology
- Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
- (2020) June Kaplow et al. Alzheimers & Dementia
- Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
- (2020) David Matuskey et al. ANNALS OF NEUROLOGY
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
- (2020) Mohammad Shahnawaz et al. NATURE
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood neurofilament light levels segregate treatment effects in multiple sclerosis
- (2020) Bénédicte Delcoigne et al. NEUROLOGY
- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
- (2020) Renaud La Joie et al. Science Translational Medicine
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
- (2020) Nicolai Franzmeier et al. Nature Communications
- Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
- (2020) Marcello Rossi et al. ACTA NEUROPATHOLOGICA
- In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
- (2020) Adam P. Mecca et al. Alzheimers & Dementia
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- Protein transmission in neurodegenerative disease
- (2020) Chao Peng et al. Nature Reviews Neurology
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
- (2020) Antoine Leuzy et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies
- (2020) Wolfgang Singer et al. ANNALS OF NEUROLOGY
- 18F-MK-6240 PET for early and late detection of neurofibrillary tangles
- (2020) Tharick A Pascoal et al. BRAIN
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
- (2020) Antoinette O’Connor et al. MOLECULAR PSYCHIATRY
- Multi-tracer model for staging cortical amyloid deposition using PET imaging
- (2020) Lyduine E. Collij et al. NEUROLOGY
- Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
- (2020) Michael J. Pontecorvo et al. EJNMMI Research
- Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
- (2020) Nicholas C. Cullen et al. Annals of Clinical and Translational Neurology
- Predicting future rates of tau accumulation on PET
- (2020) Clifford R Jack et al. BRAIN
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Cryo-EM structures of tau filaments
- (2020) Sjors HW Scheres et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- A Comprehensive View on MRI Techniques for Imaging Blood-Brain Barrier Integrity
- (2020) Elles P. Elschot et al. INVESTIGATIVE RADIOLOGY
- Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field
- (2020) Marthe Smedinga et al. JOURNAL OF NEUROLOGY
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue from Parkinson's Disease Patients
- (2020) Sireesha Manne et al. MOVEMENT DISORDERS
- Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias
- (2020) Jozef Hanes et al. NEUROLOGY
- Translating genetic risk of Alzheimer’s disease into mechanistic insight and drug targets
- (2020) Annerieke Sierksma et al. SCIENCE
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
- (2020) Inge M. W. Verberk et al. Alzheimers Research & Therapy
- Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
- (2020) Zerui Wang et al. JAMA Neurology
- The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
- (2020) Ruben Smith et al. BRAIN
- CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
- (2020) Kanta Horie et al. BRAIN
- Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
- (2020) Hendrik Wesseling et al. CELL
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
- (2019) Daniel A. Nation et al. NATURE MEDICINE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
- (2019) Rik Ossenkoppele et al. NEUROLOGY
- Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
- (2019) Un Jung Kang et al. MOVEMENT DISORDERS
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
- (2019) Peter T Nelson et al. BRAIN
- A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
- (2019) Michael J Pontecorvo et al. BRAIN
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NFL is a marker of treatment response in children with SMA treated with nusinersen
- (2019) Bob Olsson et al. JOURNAL OF NEUROLOGY
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
- (2019) Niklas Mattsson et al. JAMA Neurology
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- Validation of the movement disorder society criteria for the diagnosis of 4‐repeat tauopathies
- (2019) Gesine Respondek et al. MOVEMENT DISORDERS
- Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
- (2019) Per Borghammer et al. Journal of Parkinsons Disease
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
- (2019) Kaj Blennow et al. BRAIN
- Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
- (2019) Kaj Blennow et al. Scientific Reports
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- Combined neuropathological pathways account for age-related risk of dementia
- (2018) Melinda C. Power et al. ANNALS OF NEUROLOGY
- Longitudinal tau PET in ageing and Alzheimer’s disease
- (2018) Clifford R Jack et al. BRAIN
- Secondary nucleation in amyloid formation
- (2018) Mattias Törnquist et al. CHEMICAL COMMUNICATIONS
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
- (2018) Brian A Gordon et al. LANCET NEUROLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals
- (2018) Heidi I. L. Jacobs et al. NATURE NEUROSCIENCE
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
- (2018) David A. Wolk et al. JAMA Neurology
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
- (2018) Leslie M. Shaw et al. Alzheimers & Dementia
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
- (2018) Ruben Smith et al. JAMA Neurology
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis
- (2017) Giovanni Rizzo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
- (2017) Anne Maass et al. JOURNAL OF NEUROSCIENCE
- Amyotrophic lateral sclerosis
- (2017) Michael A van Es et al. LANCET
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
- (2017) Shorena Janelidze et al. NEUROBIOLOGY OF AGING
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials
- (2016) Jeff Sevigny et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
- (2016) Rik Ossenkoppele et al. BRAIN
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Accuracy of clinical diagnosis of Parkinson disease
- (2016) Giovanni Rizzo et al. NEUROLOGY
- Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases
- (2016) Heiko Braak et al. Cold Spring Harbor Perspectives in Biology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries
- (2015) Craig A. Hunter et al. Alzheimers & Dementia
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lewy body dementias
- (2015) Zuzana Walker et al. LANCET
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Mild Cognitive Impairment
- (2011) Ronald C. Petersen NEW ENGLAND JOURNAL OF MEDICINE
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- Missed and Delayed Diagnosis of Dementia in Primary Care
- (2010) Andrea Bradford et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Imaging Approaches to Parkinson Disease
- (2010) D. J. Brooks JOURNAL OF NUCLEAR MEDICINE
- Age, Neuropathology, and Dementia
- (2009) George M. Savva et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease
- (2008) Randall J. Bateman et al. Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started